Investor Presentation - First Six Months of 2021 slide image

Investor Presentation - First Six Months of 2021

Investor presentation First six months of 2021 SECURE A LEADING POSITION BY LEVERAGING FULL PORTFOLIO AND EXPANDING INTO ADJACENT AREAS 1. Rare blood disorders 2. Rare endocrine disorders 68 71 72 3. Biopharm innovation Biopharm CHRIS BOMBARDIER Chris has haemophilia B US
View entire presentation